The Neuro’s drug discovery initiative supports research by developing assays shared with the scientific community
In the past 40 years, the model of drug discovery used by the pharmaceutical industry, while proving successful for some applications, has produced very little for neurodegenerative diseases.
“We have to ask if there is a better way to find therapies that will modify the course of diseases, slowing or stopping them from progressing. While Open Science is not going to solve every problem, it will be a big part of the solution.”“Take Parkinson’s disease, for instance: there have been zero new disease modifying medications developed in the last 40 years, despite hundreds of millions of dollars being invested in research,” says Dr. Edward Fon, whose lab focuses on molecular and cellular research into Parkinson’s disease. “We have to ask if there is a better way to find therapies that will modify the course of diseases, slowing or stopping them from progressing. While Open Science is not going to solve every problem, it will be a big part of the solution.”
The Neuro’s drug discovery initiative aims to support research by developing assays that investigate different aspects of target cells and sharing these assays with colleagues around the world. The main vehicle for sharing assays is The Neuro’s Induced Pluripotent Stem Cell (iPSC) platform, developed recently with seed money generously donated by Sebastian van Berkom and Ghislaine Saucier.
“We can provide industry-standard assays researchers can use to test compounds,” says Thomas Durcan, another Parkinson’s researcher who manages the iPSC platform. “In collaboration with researchers at Université Laval, we reprogram blood cells from patients with neurological diseases into stem cells, and then transform the stem cells into the type of neural cells most impacted in neuropathology.”
This gives researchers the ability to compare normal and diseased states of the cells within one patient, which has long been possible for some diseases but is a novel advance for neurological research. The Centre for Drug Research and Development, a Canadian nonprofit organization that aims to speed the translation of discoveries into therapies, and the international Structural Genomics Consortium have both formed partnerships with the Tanenbaum Open Science Institute to use the iPSC platform.
“If we can identify potential compounds for targeting diseases such as Parkinson’s and share them so they can be screened and tested throughout the scientific community, we can accelerate the rate of discovery,” says Dr. Fon. “Other researchers can benefit from the resources we develop, and the chances of 100 laboratories finding something useful is much greater than that of one lab working alone. If we can come up with something leading to treatment for Parkinson’s disease, that would be an incredible payback.”
Learn more: Accelerating drug discovery with Open Science
The Latest on: Open Science
via Google News
The Latest on: Open Science
- IES is committed to advancing quality science in Mexicoon August 21, 2021 at 9:22 am
By: Jose Miguel Garcia The second open science conference begins in 2021; It gathered more than 1,700 participants from Mexico, Costa Rica, Panama, ...
- Chemists react to UK umbrella funding body’s new open access mandateon August 20, 2021 at 1:13 am
British umbrella funding agency UK Research and Innovation (UKRI) announced its long-awaited open access policy at a virtual roundtable with science minister Amanda Solloway earlier this month.
- Karger Publishers Continues to Strive for Open Scienceon August 18, 2021 at 4:21 am
Karger Publishers and ChronosHub launch partnership to further support the Open Science movement. The partnership will play a central role in supporting the transition to Open Science for Karger ...
- Open Science Hardware Accelerates Innovation, Democratizes Scienceon July 31, 2021 at 9:47 pm
Open Science Hardware (OSH)—a term used to describe openly licensed scientific tools that are available for anyone to study, modify, reproduce and distribute—is going to happen. The question that ...
- Dag Hammarskjöld Library and DESA host Open Science Conferenceon July 29, 2021 at 5:00 pm
The Dag Hammarskjöld Library (in the Department of Global Communications) and the Department of Economic and Social Affairs (DESA) recently held the second global Open Science Conference under ...
- Ontario science advisory group recommends extra curriculars resume, schools stay openon July 19, 2021 at 2:22 pm
TORONTO – Ontario’s science advisory table is recommending ... Therefore, barring catastrophic circumstances, schools should remain open for in-person learning,” the advisory table continues.
- Open science, communal culture, and women’s participation in the movement to improve scienceon April 3, 2021 at 9:09 am
Murphy M C; Mejia A F; Mejia J; Yan X; Cheryan S; Dasgupta N; Destin M; Fryberg S A; Garcia J A; Haines E L; Harackiewicz J M; Ledgerwood A; Moss-Racusin C A; Park L A; Perry S P; Ratliff K A; Rattan ...
- Royal Society Open Scienceon August 14, 2020 at 9:53 pm
An international team of researchers has found evidence of multiple waves of ancient brown bears migrating to the Japanese island of Honshu over vast periods of time. In their paper published in ...
- About ESA Open Scienceon April 23, 2020 at 1:09 am
Open science is the idea that the products and the process of science should be freely accessible (i.e. open) to everyone. This includes things like open educational materials, open access ...
via Bing News